A predictor of unfavourable outcome in neutropenic paediatric patients presenting with fever of unknown origin

Michaela Semeraro, Caroline Thomée, Estelle Rolland, Marie Cecile Le Deley, David Rosselini, Frederic Troalen, Loredana Amoroso, Marie Dubrel, Olivier Hartmann

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background. No sensitive, specific marker able to discriminate favourable or unfavourable outcome of fever of unknown origin (FUO) at diagnosis has been identified. Procalcitonin, a recently assessed infection marker, may be useful in predicting the outcome of FUO. Methods. We conducted a prospective study examining the following variables: age 0.5-22 years; solid tumour diagnosis; chemotherapy-related grade-4 febrile neutropenia (FN). A complete clinical, bacteriological and biological evaluation was performed at hospital admission (H0). Other investigations depended on clinical status. FUO was considered to be of unfavourable outcome if the fever was persistent or re-appeared at day 3 (or later), or if secondary clinical or microbiological infection occurred. To validate the results of the analysis the data set was randomly split into a training set and a validation set. Results. Out of 172 episodes of FN, 136 episodes were classified as FUO (80%). Seventy-two (53%) were included in this study. PCT values were significantly higher in episodes of unfavourable outcome (P

Original languageEnglish
Pages (from-to)284-290
Number of pages7
JournalPediatric Blood and Cancer
Volume54
Issue number2
DOIs
Publication statusPublished - Feb 2010

Fingerprint

Fever of Unknown Origin
Pediatrics
Febrile Neutropenia
Calcitonin
Infection
Fever
Prospective Studies
Drug Therapy
Neoplasms

Keywords

  • Aplasia
  • Cancer
  • Children
  • FUO
  • Procalcitonin

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Cite this

Semeraro, M., Thomée, C., Rolland, E., Le Deley, M. C., Rosselini, D., Troalen, F., ... Hartmann, O. (2010). A predictor of unfavourable outcome in neutropenic paediatric patients presenting with fever of unknown origin. Pediatric Blood and Cancer, 54(2), 284-290. https://doi.org/10.1002/pbc.22345

A predictor of unfavourable outcome in neutropenic paediatric patients presenting with fever of unknown origin. / Semeraro, Michaela; Thomée, Caroline; Rolland, Estelle; Le Deley, Marie Cecile; Rosselini, David; Troalen, Frederic; Amoroso, Loredana; Dubrel, Marie; Hartmann, Olivier.

In: Pediatric Blood and Cancer, Vol. 54, No. 2, 02.2010, p. 284-290.

Research output: Contribution to journalArticle

Semeraro, M, Thomée, C, Rolland, E, Le Deley, MC, Rosselini, D, Troalen, F, Amoroso, L, Dubrel, M & Hartmann, O 2010, 'A predictor of unfavourable outcome in neutropenic paediatric patients presenting with fever of unknown origin', Pediatric Blood and Cancer, vol. 54, no. 2, pp. 284-290. https://doi.org/10.1002/pbc.22345
Semeraro, Michaela ; Thomée, Caroline ; Rolland, Estelle ; Le Deley, Marie Cecile ; Rosselini, David ; Troalen, Frederic ; Amoroso, Loredana ; Dubrel, Marie ; Hartmann, Olivier. / A predictor of unfavourable outcome in neutropenic paediatric patients presenting with fever of unknown origin. In: Pediatric Blood and Cancer. 2010 ; Vol. 54, No. 2. pp. 284-290.
@article{9033b62ab2f546a1ba19618ce70d1643,
title = "A predictor of unfavourable outcome in neutropenic paediatric patients presenting with fever of unknown origin",
abstract = "Background. No sensitive, specific marker able to discriminate favourable or unfavourable outcome of fever of unknown origin (FUO) at diagnosis has been identified. Procalcitonin, a recently assessed infection marker, may be useful in predicting the outcome of FUO. Methods. We conducted a prospective study examining the following variables: age 0.5-22 years; solid tumour diagnosis; chemotherapy-related grade-4 febrile neutropenia (FN). A complete clinical, bacteriological and biological evaluation was performed at hospital admission (H0). Other investigations depended on clinical status. FUO was considered to be of unfavourable outcome if the fever was persistent or re-appeared at day 3 (or later), or if secondary clinical or microbiological infection occurred. To validate the results of the analysis the data set was randomly split into a training set and a validation set. Results. Out of 172 episodes of FN, 136 episodes were classified as FUO (80{\%}). Seventy-two (53{\%}) were included in this study. PCT values were significantly higher in episodes of unfavourable outcome (P",
keywords = "Aplasia, Cancer, Children, FUO, Procalcitonin",
author = "Michaela Semeraro and Caroline Thom{\'e}e and Estelle Rolland and {Le Deley}, {Marie Cecile} and David Rosselini and Frederic Troalen and Loredana Amoroso and Marie Dubrel and Olivier Hartmann",
year = "2010",
month = "2",
doi = "10.1002/pbc.22345",
language = "English",
volume = "54",
pages = "284--290",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - A predictor of unfavourable outcome in neutropenic paediatric patients presenting with fever of unknown origin

AU - Semeraro, Michaela

AU - Thomée, Caroline

AU - Rolland, Estelle

AU - Le Deley, Marie Cecile

AU - Rosselini, David

AU - Troalen, Frederic

AU - Amoroso, Loredana

AU - Dubrel, Marie

AU - Hartmann, Olivier

PY - 2010/2

Y1 - 2010/2

N2 - Background. No sensitive, specific marker able to discriminate favourable or unfavourable outcome of fever of unknown origin (FUO) at diagnosis has been identified. Procalcitonin, a recently assessed infection marker, may be useful in predicting the outcome of FUO. Methods. We conducted a prospective study examining the following variables: age 0.5-22 years; solid tumour diagnosis; chemotherapy-related grade-4 febrile neutropenia (FN). A complete clinical, bacteriological and biological evaluation was performed at hospital admission (H0). Other investigations depended on clinical status. FUO was considered to be of unfavourable outcome if the fever was persistent or re-appeared at day 3 (or later), or if secondary clinical or microbiological infection occurred. To validate the results of the analysis the data set was randomly split into a training set and a validation set. Results. Out of 172 episodes of FN, 136 episodes were classified as FUO (80%). Seventy-two (53%) were included in this study. PCT values were significantly higher in episodes of unfavourable outcome (P

AB - Background. No sensitive, specific marker able to discriminate favourable or unfavourable outcome of fever of unknown origin (FUO) at diagnosis has been identified. Procalcitonin, a recently assessed infection marker, may be useful in predicting the outcome of FUO. Methods. We conducted a prospective study examining the following variables: age 0.5-22 years; solid tumour diagnosis; chemotherapy-related grade-4 febrile neutropenia (FN). A complete clinical, bacteriological and biological evaluation was performed at hospital admission (H0). Other investigations depended on clinical status. FUO was considered to be of unfavourable outcome if the fever was persistent or re-appeared at day 3 (or later), or if secondary clinical or microbiological infection occurred. To validate the results of the analysis the data set was randomly split into a training set and a validation set. Results. Out of 172 episodes of FN, 136 episodes were classified as FUO (80%). Seventy-two (53%) were included in this study. PCT values were significantly higher in episodes of unfavourable outcome (P

KW - Aplasia

KW - Cancer

KW - Children

KW - FUO

KW - Procalcitonin

UR - http://www.scopus.com/inward/record.url?scp=74849133825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74849133825&partnerID=8YFLogxK

U2 - 10.1002/pbc.22345

DO - 10.1002/pbc.22345

M3 - Article

VL - 54

SP - 284

EP - 290

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 2

ER -